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s It the Same or a Different
entricular Tachycardia?
n Additional Use for
efibrillator Electrograms*
esus Almendral, MD,† Francis Marchlinski, MD‡
adrid, Spain; and Philadelphia, Pennsylvania
he introduction of stored electrogram (EGM) recordings
rom the sensing and/or shocking leads of implantable
ardioverter-defibrillators (ICDs) provided the opportunity
o document the “real world” of what triggers device
herapy. Signal analysis could establish, independently of
ymptoms, if device therapy was appropriate for a ventric-
lar arrhythmia or inappropriate for a nonventricular ar-
hythmia event or abnormal lead-related activity (1–5). The
isual inspection of ICD EGMs could help differentiate if a
achycardia was ventricular or supraventricular in origin
ith a high degree of certainty (1–5). Furthermore, in
ubsequent years, a significant amount of research effort was
mplemented to establish effective automated device-based
nalysis of these EGMs to differentiate between ventricular
nd supraventricular tachycardias and minimize inappropri-
te ICD therapies (6–9).
See page 969
Importantly, analysis of ICD EGMs can be performed
or other purposes. That different, configurationally distinct
entricular tachycardia (VT) on the basis of 12-lead elec-
rocardiogram (ECG) analysis may also have configuration-
lly different ICD EGMs has been suggested in prior
eports but not completely investigated (10–12). These
rior reports suggested that the ICD EGM recorded during
T can be used as a surrogate for the 12-lead ECG in
ifferentiating among distinct monomorphic VTs and can
e used to both help guide ablation targets and track the
ecurrence of specific VTs targeted at the time of ablation
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From †Grupo Hospital de Madrid, University CEU San Pablo, Madrid, Spain; and
he ‡Hospital of the University of Pennsylvania, University of Pennsylvania Health
ystem, Philadelphia, Pennsylvania. Dr. Almendral has received honoraria for lectures
rom Medtronic, Boston Scientific, St. Jude Medical, and Johnson & Johnson. Dr.a
archlinski has received honoraria from Boston Scientific, Medtronic, Biotronik, and
t. Jude Medical.10–12). In this issue of the Journal, Yoshida et al. (13)
eport on a rigorous analysis of ICD EGM configuration
uring monomorphic VT in a group of 21 patients referred
or catheter ablation in the setting of prior myocardial
nfarction. This is the first study to report on the systematic
se of ICD EGMs to distinguish among VT configurations.
Clinical” VTs had been documented by 12-lead ECGs in
5 patients, and in 13 of those patients, 12-lead ECG
atching VTs could be induced during the electrophysi-
logic study. The investigators also recorded 12-lead ECGs
nd ICD EGMs from each induced VT. They then
ompared ICD EGMs from the 13 “clinically documented”
Ts with the ICD EGMs from 64 other 12-lead ECG
onfigurationally distinct induced VTs in these same pa-
ients. On the basis of a complex computerized analysis of
CD EGMs, 63 of 64 VTs (98%) not previously docu-
ented could be correctly identified as different from the
linical VTs. Of note, simple visual inspection of ICD
GMs was also highly accurate (96%) in distinguishing
linically documented VT from inducible and previously
ndocumented VT.
The possibility of identifying configurationally distinct
T on the basis of ICD EGM recordings has clinical
elevance for a number of reasons. First, with the increased
se of ICDs for the primary prevention of sudden death in
atients with severe structural heart disease, an increasing
roportion of patients will have ICD EGM recordings as
he only documentation of monomorphic VT. Thus, “clin-
cally documented VT” will probably be defined in the
uture only by the description of the ICD EGM. Second,
leomorphism, defined for VT by 12-lead ECG parame-
ers, reportedly has clinical relevance related to ablation
trategy and clinical outcomes (14–16). However, because
f the limited number of VT episodes for which 12-lead
CGs are recorded, the incidence of pleomorphism may be
nderestimated and its clinical import not fully studied. To
he extent that distinct ICD EGM configurations can be
sed as surrogates for distinct 12-lead ECG configurations,
he storage and analysis of the majority of VT episodes
ould allow pleomorphism to be studied in more detail and
ts prognostic implications better defined. Third, recur-
ences after VT ablation procedures could be further char-
cterized by comparison of pre-procedural, intraprocedural,
nd post-procedural ICD EGM configurations. The best
T ablation strategy might be better defined and the value
f targeting specific ECG morphologies understood.
In addition, Yoshida et al. (13) go on to describe the
patial resolution of the ICD EGM as defined by detailed
ace mapping over the entire area of bipolar EGM-defined
ow-voltage. Previous research on this same subject, using
acing from multiple left ventricular sites and blinded visual
nalysis to distinguish successive beats from the same pacing
ite from paced beats from a different site, found a relation-
hip between distance from an index pacing site and
ccuracy to identify ICD EGM as coming from a different
p
s
o
r
c
a
E
w
a
c
i
t
a
b
t
m
a
t
l
r
m
r
o
p
t
s
i
r
V
c
I
c
u
p
g
c
o
E
l
a
I
m
1
g
s
t
s
fi
s
s
o
T
t
i
n
a
a
n
n
t
o
o
t
i
p
s
t
a
c
i
d
b
T
i
t
R
H
s
1
R
981JACC Vol. 56, No. 12, 2010 Almendral and Marchlinski
September 14, 2010:980–2 An Additional Use for ICD Electrogramsacing site (17). Identification was found to be accurate if
ites were 2 cm apart (17). In accordance with these
bservations, Yoshida et al. (13) found that the mean spatial
esolution of computerized ICD EGM analysis was 8.7
m2, with the radius of a hypothetical circumference of such
n area of 1.7 cm. The spatial resolution for the 12-lead
CG, using similar methodology, appeared to be better,
ith a mean value of 2.9 cm2, and whether the much larger
rea (3 times) defined by a match in only the ICD EGM
an be targeted for successful ablation without causing
ncreased risk remains to be determined. Perhaps rather
han an area of pace match, the linear extent of a pace match
t the border zone of scar could be used to define the
oundaries of a linear ablation strategy that could block exit
o normal myocardium (18). This type of ablation would be
ore limited than a cluster of lesions aimed at covering an
rea of pace match as described by Yoshida et al. (13).
The methodology used to determine the spatial resolu-
ion in the present report has both unique value and
imitations. First, the spatial resolution was calculated in
elation to the identification of VT exit sites defined by pace
apping. This is an advantage over measurements in
elation to any other ventricular site, because this method-
logy is intended to be used in patients with VT in the
rocess of ablation. However, this methodology in turn has
he general limitation related to the identification of VT exit
ites with ECG analysis and pacing (19–24). Exit sites were
dentified by 12-lead ECG pace mapping during sinus
hythm, with these exit sites identified for only half of the
Ts in the present report. Second, the methodology used
omputerized analysis of signals for both 12-lead ECG and
CD EGM analysis, but the cutoff values for the correlation
oefficient and the root mean square difference were derived
sing the visually obtained classic “10 of 12 ECG leads
ace match” as the gold standard. By doing so, the investi-
ators include the limitations of this gross 12-lead ECG
omparison in the final analysis. In addition, the method-
logy used to determine the spatial resolution for ICD
GM is not explained in detail (“ICD EGMs were ana-
yzed in the same fashion as the 12-lead ECGs”), suggesting
n identical set of limitations. Third, if the gold standard for
CD EGM analysis was derived from 12-lead ECG pace
atch, this could have biased the entire analysis in favor of
2-lead ECG analysis compared with ICD EGM.
If the conclusions of this study are to be implemented in
eneral practice, several other limitations and possible
ources of bias should be borne in mind. First, ICD EGM
racings were filtered in a specific way by the recording
ystem (between 0.05 and 300 Hz), which is not the
ltering used for standard ICD EGM tracings, at least by
ome manufacturers. Second, both the definition of the gold
tandard and the visual analysis were performed by 2
bservers, but they were not blinded to other information.
hird, ICDs from several manufacturers were included in
he study. Although the investigators analyzed the potential
mpact of ICD manufacturer in spatial resolution and foundo significant differences, the sample size was too small for
rigorous comparison. As a result, one cannot be assured of
lack of impact of ICD manufacturer. Furthermore, the
ear-field ICD EGMs are truly bipolar in some ICDs but
ot in others, and the superior vena cava coil participates in
he coil-to-can configuration from some ICDs but not from
thers. In addition, it has been shown that the configuration
f the ICD EGM during sinus rhythm differs between 2 of
he defined brands, and these factors could potentially
nfluence spatial resolution (5). Finally, all patients had
ost-myocardial infarction VT. It is unclear if the conclu-
ions can be maintained for other VT substrates.
Despite the aforementioned limitations, we believe that
he effort to delineate information from ICD EGM analysis
s performed by Yoshida et al. (13) is seminal in nature and
ertainly a welcome investigation. Their work suggests that
n the management of VT with catheter ablation proce-
ures, ICD EGMs could become the new “standard” link
etween spontaneous phenomena and induced arrhythmias.
he investigators are pioneers in what will probably evolve
nto “the new electrocardiography of the 21st century,” and
heir work will be a much-referenced first step.
eprint requests and correspondence: Dr. Francis E. Marchlinski,
ospital of the University of Pennsylvania, Cardiovascular Divi-
ion, 3400 Spruce Street, Founders 9, Philadelphia, Pennsylvania
9004. E-mail: francis.marchlinski@uphs.upenn.edu.
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